ProPSMA: A Callout to the Nuclear Medicine Community to Change Practices with Prospective, High-Quality Data

Grants

Funding Acknowledgements

Michael Hofman thanks all the ProPSMA study investigators, clinical trial coordinators, participants and their carers, for all their dedicated efforts in the conduct of the ProPSMA Study. He also thanks the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) and The Australasian Radiopharmaceutical Trials network (ARTnet) for supporting the trial.